The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Host immune classifier to predict survival with chemoimmunotherapy in PD-L1 =50% metastatic NSCLC.
 
Vamsidhar Velcheti
Honoraria - Galvanize Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Novocure; Picture Health; Regeneron; Taiho Oncology; Takeda
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)
 
Ray Page
No Relationships to Disclose
 
Jason Akulian
Honoraria - Becton Dickinson; Intuitive Surgical; NanOlogy; Olympus
Consulting or Advisory Role - Becton Dickinson; Cook Medical; Intuitive Surgical; NanOlogy; Olympus
Research Funding - Becton Dickinson (Inst); Biodesix (Inst); NanOlogy (Inst); Tempus (Inst); Veracyte (Inst)
 
David Oubre
Stock and Other Ownership Interests - Daiichi Sankyo
Speakers' Bureau - SOBI
 
Trevor Pitcher
Employment - Biodesix
Stock and Other Ownership Interests - Biodesix
 
Wallace Akerley
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Other Relationship - Lilly